{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:36:26Z","timestamp":1760747786009,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejca.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T14:35:17Z","timestamp":1650465317000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancer"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-392X","authenticated-orcid":false,"given":"Maria S.","family":"Pino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Fabbroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Martella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Lanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela S.","family":"Ribecco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Scoccianti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Baldazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta","family":"Di Leonardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Fulignati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Molinara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Rangan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-1627","authenticated-orcid":false,"given":"Gil","family":"Goldzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Fioretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.04.008_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ejca.2022.04.008_bib2","unstructured":"Ministero della Salute; Presidenza del Consiglio dei Ministri; Istituto Superiore di Sanit\u00e0; Agenzia Nazionale per i Servizi Sanitari Regionali; Agenzia Italiana del Farmaco. Vaccinazione anti-SARS-CoV-2\/COVID-19. Piano strategico. Available online: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2986_allegato.pdf (accessed on 20 January 2021). ."},{"key":"10.1016\/j.ejca.2022.04.008_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/2159-8290.CD-20-1817","article-title":"Priority Covid-19 vaccination for patients with cancer while vaccine supply is limited","volume":"11","author":"Ribas","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2022.04.008_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.04.008_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2022.04.008_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejca.2020.08.017","article-title":"High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study","volume":"139","author":"Elkrief","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2020.09.035","article-title":"Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: a French nationwide cohort study (GCO-002 CACOVID-19)","volume":"141","author":"Li\u00e8vre","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2020.09.027","article-title":"Dutch Oncology COVID-19 consortium: outcome of COVID-19 in patients with cancer in a nationwide cohort study","volume":"141","author":"de Joode","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejca.2020.08.011","article-title":"Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies","volume":"139","author":"Saini","year":"2020","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2020.09.028","article-title":"A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19","volume":"141","author":"Yeked\u00fcz","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1470-2045(20)30314-4","article-title":"COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.04.008_bib12","article-title":"Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study","author":"Aznab","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/imt-2019-0180","article-title":"Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ejca.2022.04.008_bib14","unstructured":"COVID-19 vaccination in cancer patients: ESMO statements. Available at: https:\/\/www.esmo.org\/covid-19-and-cancer\/covid-19-vaccination. Accessed September 02, 2021."},{"key":"10.1016\/j.ejca.2022.04.008_bib15","unstructured":"Documento AIOM CIPOMO COMU. Vaccinazione COVID-19 per I pazienti oncologici. ."},{"year":"2021","series-title":"COVID-19 vaccines & patients with cancer","key":"10.1016\/j.ejca.2022.04.008_bib16"},{"key":"10.1016\/j.ejca.2022.04.008_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(21)00155-8","article-title":"Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors","volume":"22","author":"Waissengrin","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.04.008_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2675","article-title":"Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer","author":"Goshen-Lago","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2022.04.008_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.04.008_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00427-7","article-title":"Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy","volume":"22","author":"Scoccianti","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.04.008_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa102","article-title":"A systematic review and meta-analysis of cancer patients affected by a novel coronavirus","volume":"5","author":"Venkatesulu","year":"2021","journal-title":"JNCI Cancer Spectr"},{"year":"2020","series-title":"Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data","author":"Giannakoulis","key":"10.1016\/j.ejca.2022.04.008_bib22"},{"key":"10.1016\/j.ejca.2022.04.008_bib23","unstructured":"Parere della Commissione tecnico-scientifica dell\u2019AIFA in merito alla somministrazione di dosi aggiuntive di vaccini contro il SARS-CoV2\/COVID-19 (9 settembre 2021). https:\/\/www.aifa.gov.it\/documents\/20142\/1289678\/Parere_CTS_09.09.2021.pdf."},{"year":"2007","series-title":"Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials: guidance for industry","key":"10.1016\/j.ejca.2022.04.008_bib24"},{"key":"10.1016\/j.ejca.2022.04.008_bib25","first-page":"153","article-title":"The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: early data from a single-institute survey","author":"di Noia","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2021.01.066","article-title":"Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey","volume":"32","author":"Barri\u00e8re","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.04.008_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.1962","article-title":"Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer","volume":"7","author":"Villarreal-Garza","year":"2021","journal-title":"JAMA Oncol"},{"issue":"24","key":"10.1016\/j.ejca.2022.04.008_bib28","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1158\/1078-0432.CCR-21-2439","article-title":"Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution","volume":"27","author":"Di Noia","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.04.008_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejca.2021.10.013","article-title":"Evaluation of COVID-19 vaccine response in patients with cancer: an interim analysis","volume":"159","author":"Tran","year":"2021","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2022.04.008_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejca.2022.04.008_bib31","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Ds","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2022.04.008_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejca.2021.12.006","article-title":"Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment","volume":"163","author":"Amatu","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.04.008_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejca.2021.12.006","article-title":"Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients","volume":"163","author":"Patelli","year":"2022","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922002076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922002076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:37:17Z","timestamp":1760733437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922002076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"alternative-id":["S0959804922002076"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.04.008","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}